ADVM logo

Adverum Biotechnologies (ADVM) Non Current Assets

Annual Non Current Assets

$70.24 M
-$47.54 M-40.36%

31 December 2023

ADVM Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Non Current Assets

$73.30 M
-$1.09 M-1.47%

30 September 2024

ADVM Quarterly Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ADVM Non Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-40.4%+1.6%
3 y3 years+45.9%-48.7%
5 y5 years+1381.5%+93.3%

ADVM Non Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-42.7%+45.9%-48.7%+6.7%
5 y5 years-42.7%+1381.5%-48.7%+93.3%
alltimeall time-42.7%>+9999.0%-48.7%>+9999.0%

Adverum Biotechnologies Non Current Assets History

DateAnnualQuarterly
Sept 2024
-
$73.30 M(-1.5%)
June 2024
-
$74.39 M(+8.3%)
Mar 2024
-
$68.70 M(-2.2%)
Dec 2023
$102.77 M(-46.1%)
$70.24 M(-2.7%)
Sept 2023
-
$72.17 M(-23.5%)
June 2023
-
$94.29 M(-11.6%)
Mar 2023
-
$106.70 M(-9.4%)
Dec 2022
$190.59 M(-39.9%)
$117.78 M(-1.1%)
Sept 2022
-
$119.12 M(-7.6%)
June 2022
-
$128.92 M(+1.3%)
Mar 2022
-
$127.28 M(+3.8%)
Dec 2021
$317.14 M(-27.0%)
$122.58 M(-14.1%)
Sept 2021
-
$142.75 M(+2.1%)
June 2021
-
$139.88 M(+170.6%)
Mar 2021
-
$51.70 M(+7.4%)
Dec 2020
$434.44 M(+147.0%)
$48.13 M(+0.2%)
Sept 2020
-
$48.01 M(-1.0%)
June 2020
-
$48.49 M(+0.7%)
Mar 2020
-
$48.15 M(+2.8%)
Dec 2019
$175.87 M
$46.86 M(+23.6%)
Sept 2019
-
$37.92 M(+29.3%)
June 2019
-
$29.32 M(+5.1%)
DateAnnualQuarterly
Mar 2019
-
$27.91 M(+488.7%)
Dec 2018
$208.75 M(+7.7%)
$4.74 M(+27.0%)
Sept 2018
-
$3.73 M(-56.9%)
June 2018
-
$8.66 M(+8.8%)
Mar 2018
-
$7.96 M(-2.5%)
Dec 2017
$193.74 M(-14.0%)
$8.16 M(-6.0%)
Sept 2017
-
$8.69 M(-2.8%)
June 2017
-
$8.94 M(-3.8%)
Mar 2017
-
$9.29 M(-0.2%)
Dec 2016
$225.27 M(-13.7%)
$9.31 M(-55.0%)
Sept 2016
-
$20.68 M(-0.5%)
June 2016
-
$20.77 M(+460.7%)
Mar 2016
-
$3.71 M(+11.4%)
Dec 2015
$260.99 M(+62.8%)
$3.33 M(-4.1%)
Sept 2015
-
$3.47 M(+12.5%)
June 2015
-
$3.08 M(+97.8%)
Mar 2015
-
$1.56 M(-4.2%)
Dec 2014
$160.28 M(>+9900.0%)
$1.63 M(+79.7%)
Sept 2014
-
$906.00 K(-51.9%)
June 2014
-
$1.89 M(+443.2%)
Mar 2014
-
$347.00 K(+31.9%)
Dec 2013
$822.00 K(+115.2%)
$263.00 K
Dec 2012
$382.00 K
-

FAQ

  • What is Adverum Biotechnologies annual long term assets?
  • What is the all time high annual non current assets for Adverum Biotechnologies?
  • What is Adverum Biotechnologies annual non current assets year-on-year change?
  • What is Adverum Biotechnologies quarterly long term assets?
  • What is the all time high quarterly non current assets for Adverum Biotechnologies?
  • What is Adverum Biotechnologies quarterly non current assets year-on-year change?

What is Adverum Biotechnologies annual long term assets?

The current annual non current assets of ADVM is $70.24 M

What is the all time high annual non current assets for Adverum Biotechnologies?

Adverum Biotechnologies all-time high annual long term assets is $122.58 M

What is Adverum Biotechnologies annual non current assets year-on-year change?

Over the past year, ADVM annual long term assets has changed by -$47.54 M (-40.36%)

What is Adverum Biotechnologies quarterly long term assets?

The current quarterly non current assets of ADVM is $73.30 M

What is the all time high quarterly non current assets for Adverum Biotechnologies?

Adverum Biotechnologies all-time high quarterly long term assets is $142.75 M

What is Adverum Biotechnologies quarterly non current assets year-on-year change?

Over the past year, ADVM quarterly long term assets has changed by +$1.12 M (+1.55%)